Literature DB >> 15508077

Computed tomographic imaging of hepatocellular carcinoma.

Richard L Baron1, Giuseppe Brancatelli.   

Abstract

The ability of x-ray computed tomography (CT) to detect and characterize liver lesions has been one of the most studied issues in radiology during the past 20 years. Technological advances, combined with increased knowledge about the pathophysiological characteristics of these tumors, have dramatically increased the ability to detect and characterize large hepatocellular carcinomas (HCCs). Nonetheless, detection and characterization of early and small HCC lesions remains a difficult task. We review the imaging appearances of HCC on CT and discuss the sensitivity and specificity of computed tomographic imaging in screening patients with cirrhosis for HCC.

Entities:  

Mesh:

Year:  2004        PMID: 15508077     DOI: 10.1053/j.gastro.2004.09.027

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  11 in total

Review 1.  Management of solitary 1 cm to 2 cm liver nodules in patients with compensated cirrhosis: a decision analysis.

Authors:  Karen E Bremner; Ahmed M Bayoumi; Morris Sherman; Murray D Krahn
Journal:  Can J Gastroenterol       Date:  2007-08       Impact factor: 3.522

Review 2.  Infiltrating hepatocellular carcinoma: seeing the tree through the forest.

Authors:  Aram Demirjian; Peter Peng; Jean-Francois H Geschwind; David Cosgrove; Jacob Schutz; Ihab R Kamel; Timothy M Pawlik
Journal:  J Gastrointest Surg       Date:  2011-07-02       Impact factor: 3.452

3.  Interobserver variability in target volume delineation of hepatocellular carcinoma : An analysis of the working group "Stereotactic Radiotherapy" of the German Society for Radiation Oncology (DEGRO).

Authors:  E Gkika; S Tanadini-Lang; S Kirste; P A Holzner; H P Neeff; H C Rischke; T Reese; F Lohaus; M N Duma; K Dieckmann; R Semrau; M Stockinger; D Imhoff; N Kremers; M F Häfner; N Andratschke; U Nestle; A L Grosu; M Guckenberger; T B Brunner
Journal:  Strahlenther Onkol       Date:  2017-07-10       Impact factor: 3.621

Review 4.  Guide for diagnosis and treatment of hepatocellular carcinoma.

Authors:  Magdy Hamed Attwa; Shahira Aly El-Etreby
Journal:  World J Hepatol       Date:  2015-06-28

5.  Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients.

Authors:  Valeria R Mas; Daniel G Maluf; Kellie J Archer; Kenneth Yanek; Bridgette Williams; Robert A Fisher
Journal:  Mol Med       Date:  2006 Apr-Jun       Impact factor: 6.354

6.  Transarterial chemoembolization plus sorafenib: a sequential therapeutic scheme for HCV-related intermediate-stage hepatocellular carcinoma: a randomized clinical trial.

Authors:  Domenico Sansonno; Gianfranco Lauletta; Sabino Russi; Vincenza Conteduca; Loredana Sansonno; Franco Dammacco
Journal:  Oncologist       Date:  2012-02-14

Review 7.  Diagnosis of hepatocellular carcinoma.

Authors:  Asmaa I Gomaa; Shahid A Khan; Edward L S Leen; Imam Waked; Simon D Taylor-Robinson
Journal:  World J Gastroenterol       Date:  2009-03-21       Impact factor: 5.742

8.  High expressions of vascular endothelial growth factor and platelet-derived endothelial cell growth factor predict poor prognosis in alpha-fetoprotein-negative hepatocellular carcinoma patients after curative resection.

Authors:  Jie Hu; Yang Xu; Zao-Zhuo Shen; Zheng Wang; Qing Lu; Guo-Huan Yang; Zheng-Bin Ding; Jia Fan; Jian Zhou
Journal:  J Cancer Res Clin Oncol       Date:  2009-04-07       Impact factor: 4.553

9.  Hepatocellular carcinoma: management of an increasingly common problem.

Authors:  Gary L Davis; Jane Dempster; James D Meler; Douglas W Orr; Mark W Walberg; Brian Brown; Brian D Berger; John K O'Connor; Robert M Goldstein
Journal:  Proc (Bayl Univ Med Cent)       Date:  2008-07

Review 10.  Area extraction of the liver and hepatocellular carcinoma in CT scans.

Authors:  Kwang-Baek Kim; Chang Won Kim; Gwang Ha Kim
Journal:  J Digit Imaging       Date:  2007-09-06       Impact factor: 4.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.